Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections
Author:
Affiliation:
1. Department of Medicine; Oregon Health & Science University; Portland OR USA
2. Dallas Diabetes and Endocrine Center at Medical City; Dallas TX USA
3. Sanofi US, Inc.; Bridgewater NJ USA
4. Analysta; Belle Mead NJ USA
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12225/fullpdf
Reference13 articles.
1. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients;Riddle;Diabetes Care,2003
2. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study;Yki-Järvinen;Diabetologia,2006
3. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes;Janka;Diabetes Care,2005
4. Basal insulin or premix analogue therapy in type 2 diabetes patients;Raskin;Eur J Intern Med,2007
5. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial;Bretzel;Lancet,2008
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Patients with type 2 diabetes who achieve reduced postprandial glucose levels during insulin intensive therapy may have a better recovery of β-cell function;Diabetes Research and Clinical Practice;2024-09
2. Insulin Inertia Among People With Type 2 Diabetes Mellitus in Qatar: The INERT‐Q Study;Endocrinology, Diabetes & Metabolism;2024-06-06
3. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15
4. A prospective, multicentre, randomized, open-label comparison of a long-acting basal insulin analog glargine plus glulisine with premixed insulin in insulin naïve patients with Type 2 diabetes – A study from India;Primary Care Diabetes;2024-04
5. Gender representation in drug development studies for diabetes mellitus. A systematic review;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3